PNC Financial Services Group’s Dare Bioscience DARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$938 Buy
+1,100
New +$1.29K ﹤0.01% 5009
2024
Q3
– Sell
-250
Closed -$1.01K – 4821
2024
Q2
$1.01K Sell
250
-117
-32% -$567 ﹤0.01% 4424
2024
Q1
$2.16K Hold
367
– – ﹤0.01% 4178
2023
Q4
$1.36K Hold
367
– – ﹤0.01% 4257
2023
Q3
$2.03K Hold
367
– – ﹤0.01% 4243
2023
Q2
$4K Hold
367
– – ﹤0.01% 4170
2023
Q1
$4.58K Hold
367
– – ﹤0.01% 4067
2022
Q4
$3.65K Hold
367
– – ﹤0.01% 4097
2022
Q3
$4K Buy
367
+84
+30% +$1.15K ﹤0.01% 4010
2022
Q2
$4K Buy
283
+83
+42% +$1.25K ﹤0.01% 4041
2022
Q1
$4K Hold
200
– – ﹤0.01% 4047
2021
Q4
$5K Buy
200
+83
+71% +$1.71K ﹤0.01% 3968
2021
Q3
$2K Buy
+117
New +$2.31K ﹤0.01% 4096
2018
Q2
– Sell
-4
Closed – – 4154
2018
Q1
$0 Buy
+4
New +$81 ﹤0.01% 4188

Other funds holding DARE

PNC Financial Services Group's DARE Position: Q3 2026 in Review

PNC Financial Services Group opened a new position in Dare Bioscience (DARE) in Q3 2026: 1,100 shares worth $938. The stake represents ﹤0.01% of the portfolio and ranks #5009 among its holdings. This is a return to the name: PNC Financial Services Group previously reported a position in DARE as recently as Q2 2024.

PNC Financial Services Group first reported a position in DARE in Q1 2018 and has held it in 14 quarters since. The position peaked at $5K in Q4 2021. 35 funds tracked by Wall St. Rank hold DARE as of Q3 2026.

  • PNC Financial Services Group held 1,100 shares of Dare Bioscience worth $938 as of Q3 2026.
  • Dare Bioscience was a new PNC Financial Services Group position in Q3 2026.
  • Dare Bioscience made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #5009 holding.
  • PNC Financial Services Group first reported a position in Dare Bioscience in Q1 2018 and has held it in 14 quarters since.
  • PNC Financial Services Group's Dare Bioscience position peaked at $5K in Q4 2021.
  • 35 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.